Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib‐resistant non‐small cell lung cancer cells with acquired <i>MET</i> amplification
Takeshi Yoshida(Moffitt Cancer Center), Kazuhiko Nakagawa(Dana-Farber Cancer Institute)
Cited by 60
Related Papers
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
|British Journal of Cancer|2014|355
Role of ERK-BIM and STAT3-Survivin Signaling Pathways in ALK Inhibitor–Induced Apoptosis in EML4-ALK–Positive Lung Cancer
|Clinical Cancer Research|2011|141
Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
|British Journal of Cancer|2011|120